Thermogenic Characterization and Antifungal Susceptibility of Candida auris by Microcalorimetry

被引:11
|
作者
Di Luca, Mariagrazia [1 ,2 ]
Koliszak, Anna [1 ]
Karbysheva, Svetlana [1 ,3 ,4 ,5 ,6 ]
Chowdhary, Anuradha [7 ]
Meis, Jacques E. [8 ,9 ]
Trampuz, Andrej [1 ,3 ,4 ,5 ,6 ]
机构
[1] Charite Univ Med Berlin, BIH Ctr Regenerat Therapies, D-10117 Berlin, Germany
[2] Univ Pisa, Dept Biol, Via San Zeno 37, I-56127 Pisa, Italy
[3] Charite Univ Med Berlin, D-10117 Berlin, Germany
[4] Free Univ Berlin, D-10117 Berlin, Germany
[5] Humboldt Univ, D-10117 Berlin, Germany
[6] Berlin Inst Hlth, Ctr Musculoskeletal Surg, D-10117 Berlin, Germany
[7] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 11007, India
[8] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, NL-6532 SZ Nijmegen, Netherlands
[9] Canisius Wilhelmina Hosp, Ctr Expertise Mycol Radboudumc, NL-6532 SZ Nijmegen, Netherlands
关键词
Candida auris; biofilm; antifungal resistance; isothermal microcalorimetry; Metschnikowiaceae Glade; EPIDEMIOLOGY; GROWTH;
D O I
10.3390/jof5040103
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida auris has emerged globally as a multidrug-resistant fungal pathogen. Isolates of C. auris are reported to be misidentified as Candida haemulonii. The aim of the study was to compare the heat production profiles of C. auris strains and other Candida spp. and evaluate their antifungal susceptibility using isothermal microcalorimetry. The minimum heat inhibitory concentrations (MHIC) and the minimum biofilm fungicidal concentration (MBFC) were defined as the lowest antimicrobial concentration leading to the lack of heat flow production after 24 h for planktonic cells and 48 h for biofilm-embedded cells. C. auris exhibited a peculiar heat production profile. Thermogenic parameters of C. auris suggested a slower growth rate compared to Candida lusitaniae and a different distinct heat profile compared to that of C. haemulonii species complex strains, although they all belong to the Metschnikowiaceae Glade. Amphotericin B MHIC and MBFC were 0.5 mu g/mL and >= 8 mu g/mL, respectively. C. auris strains were non-susceptible to fluconazole at tested concentrations (MHIC > 128 mu g/mL, MBFC > 256 mu g/mL). The heat curve represents a fingerprint of C. auris, which distinguished it from other species. Treatment based on amphotericin B represents a potential therapeutic option for C. auris infection.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Candida auris isolates from UK outbreaks: phenotypic and phylogenetic features and antifungal susceptibility profiles
    Szekely, A.
    Borman, A. M.
    Johnson, E.
    MYCOSES, 2017, 60 : 127 - 128
  • [22] Candida auris: Epidemiology, biology, antifungal resistance, and virulence
    Du, Han
    Bing, Jian
    Hu, Tianren
    Ennis, Craig L.
    Nobile, Clarissa J.
    Huang, Guanghua
    PLOS PATHOGENS, 2020, 16 (10)
  • [23] Candida auris: The Canary in the Mine of Antifungal Drug Resistance
    Montoya, Marhiah C.
    Moye-Rowley, W. Scott
    Krysan, Damian J.
    ACS INFECTIOUS DISEASES, 2019, 5 (09): : 1487 - 1492
  • [24] Antifungal activity of nitroxoline against Candida auris isolates
    Fuchs, Frieder
    Hof, Herbert
    Hofmann, Sandra
    Kurzai, Oliver
    Meis, Jacques F.
    Hamprecht, Axel
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (11) : 1697.e7 - 1697.e10
  • [25] Antifungal activity of nikkomycin Z against Candida auris
    Bentz, Meghan L.
    Nunnally, Natalie
    Lockhart, Shawn R.
    Sexton, D. Joseph
    Berkow, Elizabeth L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (06) : 1495 - 1497
  • [26] Candida auris Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS
    Vatanshenassan, Mansoureh
    Boekhout, Teun
    Meis, Jacques F.
    Berman, Judith
    Chowdhary, Anuradha
    Ben-Ami, Ronen
    Sparbier, Katrin
    Kostrzewa, Markus
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [27] Identification, clinical profile, antifungal susceptibility pattern of candida auris from a tertiary care center in india
    Danni, Mary Kiran
    Kindo, Anupma Jyoti
    Jayalakshmi, J.
    Renuka, M. K.
    MEDICAL MYCOLOGY, 2022, 60 (SUPP 1) : 54 - 54
  • [28] Genomic epidemiology and antifungal-resistant characterization of Candida auris, Colombia, 2016-2021
    Misas, Elizabeth
    Escandon, Patricia L.
    Gade, Lalitha
    Caceres, Diego H.
    Hurst, Steve
    Le, Ngoc
    Min, Brian
    Lyman, Meghan
    Duarte, Carolina
    Chow, Nancy A.
    MSPHERE, 2024, 9 (02)
  • [29] What Is New in Candida Infections? T2Candida, Antifungal Stewardship, and Candida auris
    Clancy, Cornelius J.
    Nguyen, M. Hong
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2020, 12 (01) : 1 - 12
  • [30] Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization
    Castanheira, Mariana
    Deshpande, Lalitagauri M.
    Rhomberg, Paul R.
    Carvalhaes, Cecilia G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (10)